Billam AG was established in 2000 as a specialist investment vehicle, with particular interests in the convergence of digital and bio technologies where opportunities for rational design, discovery and control are addressed in computer based models. In September 2003 the entire share capital of Billam AG, based in Switzerland, was acquired by Centurion Science.

Billam AG Investment Strategy is clearly focused on Early Stage Research Projects and Quoted Growth Stocks where, key to its Policy of Synergistic Investing, it embraces the opportunities that convergent areas of scientific research potentially present to investee companies within its Portfolio.